MGS has introduced the Auto-injector Reimagined (A.i.r.) drug-delivery device platform, drawing on its own history of creating unique designs and manufacturing millions of auto-injector sub-assemblies ...

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and Diagn ...